N. Khan
发表论文 46 篇 · 总被引 1270 次 · h-index 13
代表论文
- Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study (2022 · RMD Open · 被引 90)
- Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials (2021 · Annals of the Rheumatic Diseases · 被引 69)
- Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study (2024 · RMD Open · 被引 28)
- MACE and VTE across upadacitinib clinical trial programmes in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis (2023 · RMD Open · 被引 28)
- Impact of Upadacitinib on Laboratory Parameters and Related Adverse Events in Patients with RA: Integrated Data Up to 6.5 Years (2024 · Rheumatology and Therapy · 被引 15)
- Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open‐Label, Phase 1 Trial (2024 · Arthritis care & research · 被引 15)